Related Experiment Video
Updated: Jun 29, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer
Isabel Baroja1,2, Nikolaos C Kyriakidis3, Georg Halder4
1Cancer Research Group, Faculty of Engineering and Applied Sciences, Universidad de Las Américas, Quito, Ecuador.
Abstract:
Hyperactivation of YAP/TAZ, the Hippo pathway downstream effectors, is common in human cancer. The requirement of YAP/TAZ for cancer cell survival in preclinical models, prompted the development of pharmacological inhibitors that suppress their transcriptional activity. However, systemic YAP/TAZ inhibition may sometimes have unpredictable patient outcomes, with limited or even adverse effects because YAP/TAZ action is not simply tumor promoting but also tumor suppressive in some cell types. Here, we review the role of the Hippo pathway in distinct tumor cell populations, discuss the impact of inhibiting Hippo output on tumor growth, and examine current developments in YAP/TAZ inhibitors.
Insights
Hyperactivation of YAP/TAZ (Yes-associated protein/T-and-மானது-like protein) is common in cancer. Inhibiting these Hippo pathway effectors shows promise but requires careful consideration due to their dual roles in tumor suppression and promotion.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Aberrant activation of YAP/TAZ, key downstream effectors of the Hippo pathway, is frequently observed in various human cancers.
- YAP/TAZ proteins are crucial for cancer cell survival, leading to the development of targeted pharmacological inhibitors.
Purpose of the Study:
- To review the multifaceted role of the Hippo pathway within distinct tumor cell populations.
- To discuss the implications of inhibiting Hippo pathway output on tumor progression and growth.
- To examine the current landscape and advancements in YAP/TAZ inhibitor development.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of the dual role of YAP/TAZ in cancer (tumor-promoting vs. tumor-suppressive).
- Evaluation of current pharmacological YAP/TAZ inhibitors and their mechanisms.
Main Results:
- YAP/TAZ activity is essential for cancer cell survival in preclinical models.
- Systemic inhibition of YAP/TAZ can lead to unpredictable patient outcomes due to context-dependent functions.
- YAP/TAZ exhibit both tumor-promoting and tumor-suppressive roles depending on the cellular context.
Conclusions:
- The Hippo pathway and its effectors YAP/TAZ play complex roles in cancer, necessitating a nuanced approach to therapeutic inhibition.
- Understanding the cell-type-specific functions of YAP/TAZ is critical for developing effective and safe cancer therapies.
- Further research into YAP/TAZ inhibitors is needed to optimize their clinical application and mitigate potential adverse effects.
Related Concept Videos
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

